Bio, Inc. (THRD) has experienced a notable downturn, touching a 52-week low of $5.58. This latest price point reflects a significant retreat from more favorable positions over the past year, with the ...

Fintel reports that on January 9, 2025, Barclays downgraded their outlook for Harmonic (NasdaqGS:HLIT) from Overweight to ...

TransMedics Group Posts Weak Results, Joins Harmonic, Crocs, D.R. Horton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ...

Currently, Harmonic is a Zacks Rank #3 (Hold ... At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected. Trillions of dollars in ...

Check the time stamp on this data. Updated AI-Generated Signals for Harmonic Inc. (HLIT) available here: HLIT. Type a few ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.30% of ...

Harmonic (NASDAQ: HLIT) today announced it will release its fourth quarter and full year 2024 financial results after the ...

Barclays downgraded Harmonic (HLIT) to Equal Weight from Overweight with a price target of $14, down from $17. The firm cites expected ...

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the ...

For Third Harmonic Bio, Stifel emphasized the significance ... InvestingPro analysis indicates the stock is fairly valued based on its proprietary Fair Value model. In other recent news, Celldex ...

Long covers the Technology sector, focusing on stocks such as Apple, Pure Storage, and Harmonic. Harmonic has an analyst consensus of Moderate Buy, with a price target consensus of $15.93.